About

Publications While At HealthPartners

selected publications

Journal Article

Association of fenofibrate therapy with long-term cardiovascular risk in statin-treated patients with type 2 diabetes. 

JAMA cardiology. 2017

Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial. 

Diabetes care. 2014

Long-term effects of intensive glucose lowering on cardiovascular outcomes. 

New England Journal of Medicine. 2011

Effects of combination lipid therapy in type 2 diabetes mellitus. 

New England Journal of Medicine. 2010

Effects of intensive blood-pressure control in type 2 diabetes mellitus. 

New England Journal of Medicine. 2010

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. 

Diabetes care. 2010

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. 

BMJ (Clinical research ed.). 2010

Effects of intensive glucose lowering in type 2 diabetes. 

New England Journal of Medicine. 2008

Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods Am J Cardiol

2007

Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Am J Cardiol

2007

presentations

Presentation

Effect of fenofibrate therapy on cardiovascular disease in men vs women with type 2 diabetes in the ACCORD-Lipid Trial [presentation], American Heart Association (AHA) Scientific Sessions

Hypertriglyceridemia and low HDL-C predicts fenofribrate response in the ACCORD-Lipid Trial [presentation], American Heart Association (AHA) Scientific Sessions

Contact

full name

R. P. Byington

RP Byington

Quick Info

 

Collaboration

Co-author network

Map of science